Abstract. Sera from 102 black patients with primary hepatocellular carcinoma (PHC) and hepatitis B surface antigenemia were tested for immunoglobulin M antibody against hepati.is B core (IgM anti-HBc), hepatitis B e antigen (HBeAg), and hepatitis B viral (HBV) DNA. Their prevalcnces were compared to those of a control group of 124 age and sex matched black HBV carriers without tumor. IgM anti-HBc was present in 68.6%, HBeAg in 32.3%, and HBV-DNA in 26.7% of the patients. In the control population, IgM antiHBc was present in 45%, HBeAg was detected in 3.2%, and HBV-DNA in 25.8%. We conclude that IgM anti-HBc is present appreciably more often than either HBeAg or HB -DNA in patients with PHC. HBeAg or IgM anti-HBc in serum of HBsAg positive carriers may predict an added risk of PHC development in South African blacks.
-I
Commercially available tests designed to de-with HBsAg positive PHC, and to compare the tect immunoglobulin M antibody to the hepatitis frequency of these markers in HBV carriers with B virus core antigen (IgM anti-Hl3c) in serum PHC to HBV carriers without the tumor. enables this antibody to be detected in patients with acute hepatitis B, and in some patients with chronic hepatitis B virus infection.' 2 Recently,
MATERIALS AND METHODS
sensitive radioimmunoassays capable of detecting much lower titers oflgM anti-HBc in patients One hundred two hepatitis-B surface antigen with chronic hepatitis B have been developed.
2 I (HBsAg) positive South African blacks with hislgM anti-HBc is demonstrable by sensitive ra-tologically proven PHC were studied. Their ages dioimmunoassay in the majority of hepatitis B were 16-70 years with a mean of 39.3 years; there e antigen (HBeAg) positive carriers with active were 94 men and 8 women. hepatic disease. However, the relation between lgM anti HBc was measured in the patient's serum IgM anti-HlBc, markers of H1BV replicasera using a solid-phase antibody-capture ration in serum, such as Hl3eAg and HBV-DNA, dioimmunoassay, as previously described.-Reand disease activity is not a simple one, and resuits were expressed as a ratio of cpm in wells quires further elucidation, containing test sera (P) to the mean cpm of wells IgM anti-HI3c has recently been shown to be containing negative sea (N). A P/N ratio of -2.1 present in the serum of patients with HBV rewas considered positive. lated primary hepatocellular carcinoma (PHC) HBV-DNA was measured in all serum samappreciably more often than in a control HBsAg pies by the following method: 300 ul of serum * positive population.' In a previous study, we was incubated for 2 hr at 70°C in 0.1 M sodium found HBeAg to be the most sensitive and HBV-acetate buffer, 2% SDS, and 50 ug/ml of yeast DNA polymerase the least sensitive marker of RNA to which was added I mg of proteinase K vial replication in South African blacks with (Merck Sharp & Dohme, Rahway, NJ). The DNA PHC. The purpose of the present study was to was extracted with 2 phenol-chloroform-isoamyl determine and correlate the prevalence of IgM alcohol extractions. The aqueous phase was then anti-HBc, HBV-DNA, and HI3eAg in patients denatured with 1.0 M NaOH, neutralized, and 50 p! immediately spotted onto a nitrocellulose Accepted 21 May 1988.
filter. After washing with 6 x SSC, the dried and HBV-DNA in serum. The prevalence of these markers was con-
The interrelation between 1gM and HBc, pared to a control group of 124 consecutively HBcAg, and HBV-DNA is shown in Table 1 . referred South African blacks with chronic hep-One or another of the 3 markers of HBV repliatitis B without PHC. These patients were refer-cation was present in 76.2% of the patients. The rals to a screening program to detect small PHC IgM antiHBc serum levels were not age related. in asymptomatic carriers. There were 116 men Patients -s30 years of age had a P/N mean conand 8 women, 21-60 years ofage (mean age 36 centration of4.1, patients aged ->50 years ofage years). Seventy-six percent were rural adult biacks had a mean P/N concentration of 5.0 (P > 0.05). in whom the disease is known to be predomi-The prevalence ofHBeAg, HBV-DNA, and IgM nantly acquired in childhood." Because liver anti-HBc in the control population are shown in biopsies were not performed for ethical reasons comparison with those in the PHC patients in in the control group, a comparison of the liver Table 2 . Of 116 anti-HBe positive carriers, 50 disease in the patient and control group was not (43.1%) were IgM anti-HBc positive. possible.
Possible differences in the prevalences of the DISCUSSION markers were analyzed statistically using the Chi square test with Yates' modification for small
The findings in this study are consistent with numbers, and Fisher's exact test.
those of previous investigations which showed that the majority of patients with HBV associ-RESULTS ated PHC have low levels of viral replication. Most of our patients were HBeAg negative, and Detectable serum levels oflgM anti-HBc were less than 20% were positive for both HBeAg and present in 68.6% (70/102) of the PHC patients. HBV-DNA. Although most were negative for HBeAg, a higher proportion were HBeAg posibe a sensitive index of HBcAg production. Thus tive than the asymptomatic HBV carrier without the majority of HBeAg-negative, HBV-DNA PHC.
polymerase HBeAg differs from that reported in Western and in the majority of our patients may indicate low Chinese carriers, we believe that the asymptomgrade HBV replication, or at least a relatively atic, age, sex, and ethnically matched HBV carrecent phase of HBV replication. riers are valid and appropriate controls to com-
The rclation between HBV replication, HBeAg pare the serological status of HBV infected and HBV-DNA in serum, disease activity, and patients to HBV infected patients with tumor, IgM anti-IBc is complex. Because certain pa-PHC ts prevalent in black South African carriers, tients with HBeAg in serum are IgM anti-HBc yetv irtually all black South African patients with negative, the latter is not always a direct marker PHC do not recall a previous history of acute or ofHBV replication and HBcAg in liver, but rathchronic hepatitis. Also, PHC together with coexer may reflect the histological and biochemical istent chronic active hepatitis or cirrhosis has activity of the disease and the complex host rebeen detected in asymptomatic carriers by alphasponse to the viral core antigen. It is primarily fetoprotein screening."' Using a radioimmuseen in patients with abnormal serum ALT valnoassay designed to yield maximum sensitivity, ues and active hepatic disease, while otherwise we found that most black patients with HBsAg healthy HBsAg carriers are usually seronegative associated PHC are positive for IgM anti-HBc.
for antibody.' 0 It could therefore be argued that
Our data confirm a similar high prevalence of IgM anti-HBc better indicates an active host reIgM anti-HBc recently reported in Koreans with sponse to ongoing HBV replication. The pres-PHC.' The lower prevalence of 48% found an ence of1gM anti-HBc in the majority ofpatients earlier study of black patients probably reflects with PHC would imply recent or possibly cona different, presumably less sensitive assay used tinued production of HlBcAg and active hepatic atat tt time. 4 disease in these patients. -The explanation for the raised serum IgM antiThere are no certain clinical, histological, or t' HBc.levvAs, in 5atients with PHC is uncertain, molecular biological criteria which will indicate There is some evidence that IgM anti-HBc may whether a particular HBsAg positive carrier will 
